SCHEMBL4902945

SCHEMBL4902945

CCN(CC)C(=O)c1ccc(Nc2cccc(-c3cnccn3)n2)nc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 1/20 0.52
HPGD P15428 5/20 0.39
LMNA P02545 3/20 0.39
HTT P42858 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ALDH1A1 P00352 4/20 0.38
KARS1 Q15046 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
FGFR1 P11362 2/20 0.37
SRC P12931 2/20 0.37
KDM4E B2RXH2 1/20 0.37
GRM1 Q13255 1/20 0.36
MAP3K5 Q99683 1/20 0.36
PIK3C3 Q8NEB9 1/20 0.36
PORCN Q9H237 1/20 0.36
HSD17B10 Q99714 1/20 0.35
MAPT P10636 1/20 0.35
OPRD1 P41143 2/20 0.35
OPRM1 P35372 1/20 0.35
NAMPT P43490 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4904498 0.89 GRM5 (0.54) GRM5HPGDLMNAALDH1A1TDP1
SCHEMBL3144922 0.83 GRM5 (0.52) GRM5HPGDLMNAHTTSMN1; SMN2
SCHEMBL4904977 0.81 GRM5 (0.50) GRM5HPGDLMNAALDH1A1FGFR1
SCHEMBL4897013 0.80 KARS1 (0.39) LMNAHTTSMN1; SMN2KARS1TDP1
Hydrochloric Acid SCHEMBL27662763 0.74 KARS1 (0.47) SMN1; SMN2ALDH1A1KARS1KDM4EMAPT
SCHEMBL4900205 0.73 NPC1 (0.40) LMNAHTTSMN1; SMN2ALDH1A1KARS1
SCHEMBL4901584 0.73 SLC2A1 (0.48) GRM5HTTSMN1; SMN2ALDH1A1KARS1
SCHEMBL4901969 0.73 KARS1 (0.40) GRM5HPGDLMNAALDH1A1KARS1
SCHEMBL5261849 0.72 KARS1 (0.40) LMNAHTTSMN1; SMN2KARS1TDP1
Hydrochloric Acid SCHEMBL4896691 0.72 SLC2A1 (0.47) GRM5HTTSMN1; SMN2ALDH1A1KARS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080108600-A1 Polycyclic Pyridines as Potassium Ion Channel Modulators ICAGEN, INC. (US) 2008-05-08 US disclosed
EP-1737852-A2 POLYCYCLIC PYRIDINES AS POTASSIUM ION CHANNEL MODULATORS Icagen, Inc. (US) 2007-01-03 EP disclosed
WO-2005100349-A2 POLYCYCLIC PYRIDINES AS POTASSIUM ION CHANNEL MODULATORS ICAGEN, INC. (US) 2005-10-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080108600-A1 Polycyclic Pyridines as Potassium Ion Channel Modulators KCNJ2, KCNH2, KCNQ1 GRM5 392/4885HPGD 1598/4885LMNA 3338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.